BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guitton J, Bandet CL, Mariko ML, Tan-Chen S, Bourron O, Benomar Y, Hajduch E, Le Stunff H. Sphingosine-1-Phosphate Metabolism in the Regulation of Obesity/Type 2 Diabetes. Cells 2020;9:E1682. [PMID: 32668665 DOI: 10.3390/cells9071682] [Cited by in Crossref: 8] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Chakrabarty S, Bui Q, Badeanlou L, Hester K, Chun J, Ruf W, Ciaraldi TP, Samad F. S1P/S1PR3 signalling axis protects against obesity-induced metabolic dysfunction. Adipocyte 2022;11:69-83. [PMID: 35094654 DOI: 10.1080/21623945.2021.2021700] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Tolksdorf C, Moritz E, Wolf R, Meyer U, Marx S, Bien-möller S, Garscha U, Jedlitschky G, Rauch BH. Platelet-Derived S1P and Its Relevance for the Communication with Immune Cells in Multiple Human Diseases. IJMS 2022;23:10278. [DOI: 10.3390/ijms231810278] [Reference Citation Analysis]
3 Mir FA, Mall R, Iskandarani A, Ullah E, Samra TA, Cyprian F, Parray A, Alkasem M, Abdalhakam I, Farooq F, Abou-samra A. Characteristic MicroRNAs Linked to Dysregulated Metabolic Pathways in Qatari Adult Subjects With Obesity and Metabolic Syndrome. Front Endocrinol 2022;13:937089. [DOI: 10.3389/fendo.2022.937089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Imierska M, Zabielski P, Roszczyc-owsiejczuk K, Sokołowska E, Pogodzińska K, Kojta I, Błachnio-zabielska A. Serine Palmitoyltransferase Gene Silencing Prevents Ceramide Accumulation and Insulin Resistance in Muscles in Mice Fed a High-Fat Diet. Cells 2022;11:1123. [DOI: 10.3390/cells11071123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Duan M, Gao P, Chen SX, Petr N, Yin K, Zhu X. Sphingosine-1-phosphate in mitochondrial function and metabolic diseases. Obes Rev 2022;:e13426. [PMID: 35122459 DOI: 10.1111/obr.13426] [Reference Citation Analysis]
6 Gurgul-Convey E. To Be or Not to Be: The Divergent Action and Metabolism of Sphingosine-1 Phosphate in Pancreatic Beta-Cells in Response to Cytokines and Fatty Acids. Int J Mol Sci 2022;23:1638. [PMID: 35163559 DOI: 10.3390/ijms23031638] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Delgado-Velandia M, Gonzalez-Marrachelli V, Domingo-Relloso A, Galvez-Fernandez M, Grau-Perez M, Olmedo P, Galan I, Rodriguez-Artalejo F, Amigo N, Briongos-Figuero L, Redon J, Martin-Escudero JC, Monleon-Salvado D, Tellez-Plaza M, Sotos-Prieto M. Healthy lifestyle, metabolomics and incident type 2 diabetes in a population-based cohort from Spain. Int J Behav Nutr Phys Act 2022;19:8. [PMID: 35086546 DOI: 10.1186/s12966-021-01219-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Blachnio-Zabielska A, Hajduch E, Le Stunff H. Editorial: The Role of Sphingolipid Metabolism in the Development of Type 2 Diabetes and Obesity. Front Endocrinol (Lausanne) 2021;12:835751. [PMID: 35069458 DOI: 10.3389/fendo.2021.835751] [Reference Citation Analysis]
9 Passaro AP, Marzuillo P, Guarino S, Scaglione F, Miraglia del Giudice E, Di Sessa A. Omics era in type 2 diabetes: From childhood to adulthood. World J Diabetes 2021; 12(12): 2027-2035 [DOI: 10.4239/wjd.v12.i12.2027] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Strassheim D, Sullivan T, Irwin DC, Gerasimovskaya E, Lahm T, Klemm DJ, Dempsey EC, Stenmark KR, Karoor V. Metabolite G-Protein Coupled Receptors in Cardio-Metabolic Diseases. Cells 2021;10:3347. [PMID: 34943862 DOI: 10.3390/cells10123347] [Reference Citation Analysis]
11 Tang Y, Plötz T, Gräler MH, Gurgul-Convey E. Sphingosine-1 Phosphate Lyase Regulates Sensitivity of Pancreatic Beta-Cells to Lipotoxicity. Int J Mol Sci 2021;22:10893. [PMID: 34639233 DOI: 10.3390/ijms221910893] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Kane JP, Pullinger CR, Goldfine ID, Malloy MJ. Dyslipidemia and diabetes mellitus: Role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus. Curr Opin Pharmacol 2021;61:21-7. [PMID: 34562838 DOI: 10.1016/j.coph.2021.08.013] [Reference Citation Analysis]
13 Shamshiddinova M, Gulyamov S, Kim HJ, Jung SH, Baek DJ, Lee YM. A Dansyl-Modified Sphingosine Kinase Inhibitor DPF-543 Enhanced De Novo Ceramide Generation. Int J Mol Sci 2021;22:9190. [PMID: 34502095 DOI: 10.3390/ijms22179190] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Reginato A, Veras ACC, Baqueiro MDN, Panzarin C, Siqueira BP, Milanski M, Lisboa PC, Torsoni AS. The Role of Fatty Acids in Ceramide Pathways and Their Influence on Hypothalamic Regulation of Energy Balance: A Systematic Review. Int J Mol Sci 2021;22:5357. [PMID: 34069652 DOI: 10.3390/ijms22105357] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
15 Juchnicka I, Kuźmicki M, Szamatowicz J. Ceramides and Sphingosino-1-Phosphate in Obesity. Front Endocrinol (Lausanne) 2021;12:635995. [PMID: 34054722 DOI: 10.3389/fendo.2021.635995] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Huo S, Sun L, Zong G, Shen X, Zheng H, Jin Q, Li H, Yin H, Lin X. Changes in Plasma Metabolome Profiles Following Oral Glucose Challenge among Adult Chinese. Nutrients 2021;13:1474. [PMID: 33925473 DOI: 10.3390/nu13051474] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Mastrocola R, Dal Bello F, Cento AS, Gaens K, Collotta D, Aragno M, Medana C, Collino M, Wouters K, Schalkwijk CG. Altered hepatic sphingolipid metabolism in insulin resistant mice: Role of advanced glycation endproducts. Free Radic Biol Med 2021;169:425-35. [PMID: 33905864 DOI: 10.1016/j.freeradbiomed.2021.04.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Wei W, Jiang W, Tian Z, Wu H, Ning H, Yan G, Zhang Z, Li Z, Dong F, Sun Y, Li Y, Han T, Wang M, Sun C. Fecal g. Streptococcus and g. Eubacterium_coprostanoligenes_group combined with sphingosine to modulate the serum dyslipidemia in high-fat diet mice. Clin Nutr 2021;40:4234-45. [PMID: 33608131 DOI: 10.1016/j.clnu.2021.01.031] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
19 Bergougnan L, Andersen G, Plum-Mörschel L, Evaristi MF, Poirier B, Tardat A, Ermer M, Herbrand T, Arrubla J, Coester HV, Sansone R, Heiss C, Vitse O, Hurbin F, Boiron R, Benain X, Radzik D, Janiak P, Muslin AJ, Hovsepian L, Kirkesseli S, Deutsch P, Parkar AA. Endothelial-protective effects of a G-protein-biased sphingosine-1 phosphate receptor-1 agonist, SAR247799, in type-2 diabetes rats and a randomized placebo-controlled patient trial. Br J Clin Pharmacol 2021;87:2303-20. [PMID: 33125753 DOI: 10.1111/bcp.14632] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]